hematopoietic system
N |
• normal numbers and percentages of immune cells in spleen, thymus and lymph
• normal bone marrow cell differentiation
|
homeostasis/metabolism
• in serum 12 h after i.v. injection of HSV-1
|
• in serum 12 h after i.v. injection of HSV-1
|
immune system
N |
• normal numbers and percentages of immune cells in spleen, thymus and lymph nodes
• normal bone marrow cell differentiation
|
• in serum 12 h after i.v. injection of HSV-1
|
• in serum 12 h after i.v. injection of HSV-1
|
• by lymphatic fibroblasts (MLFs) and bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs) after stimulation with HSV-1, cytoplasmic DNA, or cGAMP
• normal secretion by MLFs, BMDMs and BMDCs after stimulation with SeV
|
• normal secretion by MLFs, BMDMs and BMDCs after stimulation with SeV
• by lymphatic fibroblasts (MLFs) and bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs) after stimulation with HSV-1, cytoplasmic DNA, or cGAMP
|
• suppressed replication of HSV-1 in lymphatic fibroblasts (MLFs) and bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs)
• suppressed replication of HSV-1 in brain 4 days after i.v. injection of HSV-1
|
• higher survival rate and later onset of death after i.v. injection of HSV-1
|
mortality/aging
N |
• pups born at expected Mendelian ratio
|
• higher survival rate and later onset of death after i.v. injection of HSV-1
|